登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 15190 条符合本次的查询结果， 用时 1.8622553 秒

1. More about the Phase 2a Study of Baxdrostat in Primary Aldosteronism.

来源: N Engl J Med. 2026年394卷14期1456页

2. Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.

来源: N Engl J Med. 2026年394卷14期1456页

3. Measles 2025.

来源: N Engl J Med. 2026年394卷14期1456页

4. CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia. Reply.

作者: Haiqing Xiong.;Ruonan Li.;Jun Shi.
来源: N Engl J Med. 2026年394卷14期1455页

5. CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia.

作者: Shiyu Yang.;Ying Lu.
来源: N Engl J Med. 2026年394卷14期1455页

6. High-Dose Influenza Vaccine and Hospitalizations in Older Adults. Reply.

作者: Jacobo Pardo-Seco.;Federico Martinón-Torres.
来源: N Engl J Med. 2026年394卷14期1454页

7. High-Dose Influenza Vaccine and Hospitalizations in Older Adults. Reply.

作者: Niklas Dyrby Johansen.;Tor Biering-Sørensen.
来源: N Engl J Med. 2026年394卷14期1454页

8. High-Dose Influenza Vaccine and Hospitalizations in Older Adults.

作者: Yudai Kaneda.;Tatsuya Fujikawa.
来源: N Engl J Med. 2026年394卷14期1453-1454页

9. High-Dose Influenza Vaccine and Hospitalizations in Older Adults.

作者: Hao-Yun Chen.;Jhe-Cyun Liao.;Su-Boon Yong.
来源: N Engl J Med. 2026年394卷14期1453页

10. Trends in Youth-Onset Type 2 Diabetes, 2013-2024.

作者: Michael Fang.;Yunwen Xu.;Elizabeth Selvin.;Jung-Im Shin.
来源: N Engl J Med. 2026年394卷14期1451-1453页

11. Altering the Diet to Rewire Cancer.

作者: Michelle Haber.;Murray D Norris.
来源: N Engl J Med. 2026年394卷14期1447-1450页

12. Systems-Based Success for Hypertension.

作者: Sadiya S Khan.;Mark D Huffman.
来源: N Engl J Med. 2026年394卷14期1445-1446页

13. Case 10-2026: A 70-Year-Old Woman with a Racing Heart, Fatigue, and Dyspnea.

作者: Thomas K Varghese.;Eliza D Hompe.;Shaan S Khurshid.;Jo-Anne O Shepard.;Eriberto Michel.;Uma M Sachdeva.
来源: N Engl J Med. 2026年394卷14期1431-1441页

14. Necrolytic Migratory Erythema.

作者: Jia-An Hung.;Ming-Chieh Lin.
来源: N Engl J Med. 2026年394卷14期1430页

15. Celiac Disease.

作者: Joseph A Murray.;Steffen Husby.
来源: N Engl J Med. 2026年394卷14期1421-1429页
Celiac disease, a common autoimmune condition affecting approximately 1% of the population, can develop with exposure to gluten at any age. Diagnosis involves serologic testing, especially for IgA antibodies against tissue transglutaminase, and may include tests to confirm the presence of endomysial antibodies or even duodenal biopsies, although the latter are becoming less necessary. The presence of genes encoding HLA-DQ2 or HLA-DQ8 is a prerequisite for the disease. A gluten-free diet is the mainstay of treatment, but some adults have nonresponsive celiac disease, which warrants closer monitoring because of an increased risk of malignant conditions. Celiac disease also frequently co-occurs with other autoimmune disorders, such as type 1 diabetes mellitus and autoimmune thyroid disease.

16. Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.

作者: Emmanuel Feroldi.;Mark J Mulligan.;Kawsar R Talaat.;Chen Sabrina Tan.;Kristopher Paolino.;Srilatha Edupuganti.;Matthew H Collins.;Sarah L George.;Matthew Davis.;Brandon Essink.;Robert Jeanfreau.;James Peterson.;David Fried.;Ada-Maria Minutello.;Sandrine Orlando.;Joanna Korejwo.;Andrey Rojas.;Marine Dufournet.;Tifany Machabert.;Louis Devlin.;Carina Frago.; .
来源: N Engl J Med. 2026年394卷14期1399-1408页
A next-generation, live-attenuated yellow fever vaccine, vYF, was developed in Vero cells to improve vaccine supply and availability. The safety of and immune response to vYF as compared with those of the licensed yellow fever vaccine, YF-VAX, are unclear.

17. A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia.

作者: David J Kuter.;Katsuhiro Miura.;Andrea Patriarca.;Dražen Pulanić.;Atanas Radinoff.;Katya Sapunarova.;Antonia Syrigou.;Renchi Yang.;Van Anh Nguyen.;Emily Skelton.;Scarlett Wang.;Donald L Yee.;Parth Patwari.; .
来源: N Engl J Med. 2026年394卷14期1388-1398页
Immune thrombocytopenia (ITP) is a disorder of increased platelet destruction and reduced platelet production and is associated with an increased bleeding risk and a compromised quality of life. Available therapies are ineffective in at least 20% of cases. Mezagitamab is an anti-CD38 antibody that targets plasma cells, plasmablasts, and natural killer cells.

18. Multifaceted Strategies for Hypertension Control in Low-Income Patients.

作者: Katherine T Mills.;Marie Krousel-Wood.;Erin M Peacock.;Jing Chen.;Farah Allouch.;Amy K Carreras.;Siyi Geng.;Alecia Cyprian.;Gerrelda Davis.;Sonja R Fuqua.;Darie Gilliam.;Angelique Greer.;Tammy Mitchell.;Wylea Gray-Winfrey.;Shondra Williams.;Gary M Wiltz.;Keith L Winfrey.;Hua He.;Paul K Whelton.;Jiang He.
来源: N Engl J Med. 2026年394卷14期1376-1387页
Uncontrolled hypertension disproportionately affects populations that have substantial health disparities. Data regarding the effectiveness and implementation of multifaceted, team-based strategies for hypertension control among low-income patients are lacking.

19. The Whole Patient - Toward Holistic, High-Value Care.

作者: Daniel Pound.;Ishani Ganguli.;Debra Malina.
来源: N Engl J Med. 2026年394卷14期e25页

20. Silent Aspiration.

作者: Shuo-Ting Jian.;Hsiu-Nien Shen.
来源: N Engl J Med. 2026年394卷14期e26页
共有 15190 条符合本次的查询结果， 用时 1.8622553 秒